Iambic discloses Enchant and its drug-property prediction report

Iambic Therapeutics announced Enchant and released a whitepaper describing a multimodal model that combines discovery-stage and human data to predict drug properties. Its retrospective model demonstrations did not establish prospective trial success or approval of a medicine.